---
schema_version: "secwatch.filing_event.v1"
accession: "0001156039-26-000074"
form_type: "8-K"
ticker: "ELV"
cik: "0001156039"
company_name: "Elevance Health, Inc."
filed_at: "2026-11-10T21:30:20+00:00"
generated_at: "2026-11-10T21:32:30.173507+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Elevance Health reaffirms 2026 EPS guidance of at least $22.00 and adjusted EPS of at least $29.00

## Summary
- Elevance Health reaffirmed full-year 2026 shareholders' earnings guidance of at least $22.00 per diluted share.
- Guidance includes approximately $7.00 per diluted share of net unfavorable items; adjusted earnings guidance is at least $29.00.
- The company reaffirmed 2026 benefit expense ratio guidance of 90.2%, plus or minus 50 basis points.
- Officers expect to speak with investors and analysts this week and cited no other adjustment items beyond Q3 2026 earnings.

## SEC filing metadata
- accession: 0001156039-26-000074
- form_type: 8-K
- ticker: ELV
- cik: 0001156039
- company_name: Elevance Health, Inc.
- filed_at: 2026-11-10T21:30:20+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000074/0001156039-26-000074-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1156039/000115603926000074/elv-20261110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001156039-26-000074
- JSON: https://secwatch.observer/filing/0001156039-26-000074.json
- Plain text: https://secwatch.observer/filing/0001156039-26-000074.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.